Ir para o conteúdo principal

United StatesÚltimas notícias

Grafa
Health

United Therapeutics bioengineered liver passes initial human safety test

United Therapeutics (NASDAQ:UTHR) has cleared a primary safety hurdle in its ambitious effort to manufacture biological alternatives to human organs, reporting that its bioengineered external liver supported critically ill patients without serious adverse effects.

Leia mais: United Therapeutics bioengineered liver passes initial human safety test